Dr. Oh on the Hormone-Sensitive Setting in Prostate Cancer

William K. Oh, MD, chief, Division of Hematology and Medical Oncology, professor of medicine and urology, Mount Sinai Hospital, discusses the hormone-sensitive setting of prostate cancer.

The hormone-sensitive setting is a good area to test new regimens since things happen quickly, according to Oh. Since patients present with metastatic disease, their overall outcomes may be limited, but drugs will continue to be developed in this space.